Cargando…
Mevalonate Pathway Enzyme HMGCS1 Contributes to Gastric Cancer Progression
The 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is a potential regulatory node in the mevalonate pathway that is frequently dysregulated in tumors. This study found that HMGCS1 expression is upregulated in stomach adenocarcinoma samples of patients and tumorspheres of gastric cancer cells. HM...
Autores principales: | Wang, I-Han, Huang, Tzu-Ting, Chen, Ji-Lin, Chu, Li-Wei, Ping, Yueh-Hsin, Hsu, Kai-Wen, Huang, Kuo-Hung, Fang, Wen-Liang, Lee, Hsin-Chen, Chen, Chian-Feng, Liao, Chen-Chung, Hsieh, Rong-Hong, Yeh, Tien-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281414/ https://www.ncbi.nlm.nih.gov/pubmed/32349352 http://dx.doi.org/10.3390/cancers12051088 |
Ejemplares similares
-
Antidiabetic drug metformin suppresses tumorigenesis through inhibition of mevalonate pathway enzyme HMGCS1
por: Chen, Yiyan, et al.
Publicado: (2022) -
Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR
por: Ashida, Shingo, et al.
Publicado: (2017) -
Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression
por: Hsu, Kai-Wen, et al.
Publicado: (2016) -
The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis
por: Huang, Tzu-Ting, et al.
Publicado: (2015) -
MicroRNA-23a/27a/24-2 cluster promotes gastric cancer cell proliferation synergistically
por: Hua, Kate, et al.
Publicado: (2018)